SLGL
Sol-Gel Technologies Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$69.52
−0.83%Margins
Gross margin
100.0%
EBITDA margin
-967.7%
EBIT margin
-987.0%
Net margin
-910.1%
FCF margin
15.3%
-34.0%
Return on equity
-30.4%
Return on assets
-36.3%
Return on invested capital
0.03x
Asset turnover
$322.0K
Cash from operations
$15
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026